First Trimester Medication Use: What Every Expecting Parent Needs to Know
"A multi-hospital survey in Cameroon reveals crucial insights into medication safety during early pregnancy. Are you aware of the risks?"
Pregnancy is a journey filled with excitement and anticipation, but it also comes with a unique set of health considerations. One of the most critical periods is the first trimester, when the fetus is most vulnerable to developmental issues. During this time, many women may need to take medications for various reasons, but how safe are these drugs?
A recent multi-hospital survey conducted in Cameroon sheds light on this important issue, revealing some surprising trends in medication use among pregnant women. The study highlights the urgent need for increased awareness and safer medication practices during early pregnancy.
This article breaks down the key findings of this research, offering expecting parents essential information on medication safety, potential risks, and how to make informed decisions for a healthy pregnancy.
Medication Use During Pregnancy: Scope and Challenges
Medication safety during pregnancy varies significantly, with some drugs posing risks to fetal development, and most medications now include pregnancy-related risk information in FDA labeling that historically used FDA pregnancy categories. A multinational study found that herbal medicine use during pregnancy was high, though distinct regional differences existed in the herbs used and the populations using them. Researching medication effects during pregnancy remains inherently difficult because clinical trials—the standard method for testing drug safety—are largely impractical to conduct on pregnant populations, creating persistent gaps in evidence.
How Medication Safety in Pregnancy Is Studied
Organizations like Bumps (Best Use of Medicines in Pregnancy) aim to provide high-quality, freely accessible information about the benefits and safety of medicines in pregnancy to improve clinical decision-making. Researchers also use linked administrative datasets to study medication exposure—for example, one Australian study identified medication use among pregnant women by linking perinatal and pharmaceutical dispensing data from 2006 to 2012. However, observational approaches have inherent limitations compared to controlled trials, and regional differences in prescribing patterns and herbal medicine use complicate the generalizability of findings across populations.
A History of Medication Use in Pregnancy
Herbal medicines have long been used during pregnancy to treat conditions such as nausea, vomiting, and urinary tract infections, and to reduce the risk of preeclampsia, though such use occasionally causes adverse effects. Medication use during pregnancy has increased in recent decades, and some congenital anomalies, birth defects, and miscarriages have been found to be preceded by certain medication exposures. These historical patterns underscore the longstanding tension between treating pregnancy-related ailments and minimizing fetal risk, a challenge that continues to shape modern pharmacological guidelines.
Medication Use in Early Pregnancy: The Cameroon Study
Researchers interviewed 795 pregnant women attending urban and rural hospitals in Cameroon between March and August 2015. The goal was to understand the prevalence and types of medications used during the first trimester and to identify factors associated with medication use.
- High Prevalence: 68.3% of women used non-pregnancy related medications, and 42.3% used pregnancy-related orthodox medications.
- Anti-Infectives: A concerning 44% of women took anti-infectives, including antimalarials (33.6%) and antibiotics (20.8%).
- Common Medications: Analgesics (48.8%) and antianaemics (38.6%) were also frequently used.
- Self-Prescription: A notable 12.8% of women self-prescribed medications, raising concerns about potential misuse and lack of professional guidance.
Ongoing Evidence Synthesis Efforts
A PRISMA umbrella review on medication use during pregnancy is currently seeking collaborators through the Cochrane Network, reflecting an ongoing effort to systematically synthesize existing evidence on this topic. The review focuses on pregnancy, women's health, pharmacology, and evidence synthesis methodologies, including risk-of-bias assessment using established tools such as RoB 2. This initiative highlights that the evidence base for medication safety in pregnancy is still being consolidated, and that rigorous, collaborative review processes are needed to produce reliable guidance for clinicians and patients.
The Debate Over Antidepressant Safety in Pregnancy
A recent FDA panel discussion on antidepressant use during pregnancy drew criticism from medical experts for presenting a one-sided view of the risks. Research on SSRI use during pregnancy generally suggests no causal link to increased miscarriage risk once confounding factors are accounted for, and experts emphasize the importance of balanced, evidence-based discussions that weigh both risks and benefits. While no medication is without risk, the experts argue that withholding or discontinuing mental health treatment during pregnancy can carry its own significant dangers for both parent and child.
Global Trends in Medicine Use and Delivery Models
Global medicine use and spending are projected to approach four trillion defined daily doses by 2030, driven by health policy shifts, trade dynamics, and continued innovation adoption, with China expected to drive much of the growth. Alongside conventional pharmaceutical use, complementary and traditional medicines—defined as health care practices not integrated into a country's dominant health care system—remain widely used in many regions. These parallel systems of medicine create a complex landscape for pregnant individuals who may simultaneously use prescription drugs and traditional remedies, often without full awareness of potential interactions.
Protecting Your Baby: What You Can Do
The findings from this study emphasize the importance of informed decision-making and seeking professional guidance regarding medication use during pregnancy. Expecting parents should openly discuss all medications – including over-the-counter drugs and herbal remedies – with their healthcare providers. Early and regular antenatal care, coupled with clear communication, is key to ensuring a safe and healthy pregnancy for both mother and child.
When Undertreatment May Be Riskier Than Treatment
A meta-analysis of adverse perinatal outcomes in women with asthma found that international guidelines recommend continued asthma medication use during pregnancy, because poorly controlled asthma itself increases the risk of adverse outcomes. This illustrates a broader principle in prenatal pharmacology: the decision to use or avoid a medication must weigh the risks of the drug against the risks of the untreated condition. Expert commentary in the field emphasizes that informed, individualized decision-making—rather than blanket avoidance—is the most appropriate approach for managing chronic conditions during pregnancy.
Managing Chronic Conditions: The ADHD Medication Question
Personal accounts from pregnant individuals managing ADHD highlight the growing conversation about continuing stimulant medications such as lisdexamfetamine during pregnancy, with some reporting continuous use up to delivery. Meanwhile, choices about other medications during pregnancy, such as antibiotics like ciprofloxacin, require careful consideration of the risk-benefit profile specific to each condition. Conditions such as molar pregnancy also underscore that not all pregnancy complications are medication-related, but rather involve distinct medical situations requiring early diagnosis and treatment.
Early Pregnancy Signals and Systemic Medication Effects
Early pregnancy is marked by rapid hormonal and systemic changes that can produce intense symptoms including bloating, missed periods, and altered bowel patterns—changes that may complicate the assessment of medication side effects. Beyond reproductive health, many medications prescribed for systemic conditions can produce oral side effects such as dry mouth, which reduces saliva's protective effects and increases the risk of cavities and gum disease. These systemic interactions highlight the need for coordinated care between obstetricians and other specialists when managing medication use throughout pregnancy.
How Pregnant People Actually Use Medicine
Herbal medicine use during pregnancy has grown considerably worldwide and is particularly widespread in sub-Saharan Africa, where cross-sectional studies document high rates of use among pregnant women. In New Zealand, researchers observed a substantial and rapid rise in anti-nausea medicine use during pregnancy, with ondansetron use increasing from nearly zero (0.1%) to 9.1% in a short period—described by researchers as surprisingly swift adoption. These real-world patterns demonstrate that medication use in pregnancy is shaped not only by clinical guidelines but also by cultural practices, availability, and the lived experiences of pregnant individuals managing common symptoms.